News

New Life Biologics Set to Exhibit at the ISIA 20th Annual General Meeting
New Life Biologics is set to Exhibit at the 20th Annual Meeting of the ISIA Wednesday, April 30th and Thursday, May 1st, 2025 in Budapest, Hungary! For more information about New Life Biologics and our participation in the ISIA 20th Annual General Meeting. https://www.serumindustry.org/annual-meeting/20th-annual-meeting-information With a meeting theme of “Building Bridges: Enhancing

New Life Biologics Set to Showcase Innovations at BioProcess International US West Expo
New Life Biologics, a pioneering biotechnology company, is excited to announce its participation in the upcoming BioProcess International US West Expo, a premier event dedicated to advancing bioprocessing technologies and accelerating the speed to market for next-generation biologics. The Expo, renowned for its focus on innovative strategies and technologies, aims

Innovative Breakthrough: Adult Bovine Plasma as a Sustainable Alternative to FBS in Biomedical Research
In a groundbreaking study, researchers at New Life Biologics have discovered a viable alternative to FBS, a critical but often controversial component used in tissue culture within biomedical research. The study presents adult bovine plasma as a promising substitute, potentially resolving long-standing availability and logistical challenges associated with FBS. Fetal

New Life Biologics: Pioneering a Sustainable Future with Cutting-Edge Biotechnology
In an era where innovation and sustainability are paramount, New Life Biologics emerges as a leader in the biotechnology industry’s progress. With a commitment to harnessing the raw power of nature, the company is proud to announce its brand, dedicated to transforming biological products from concepts into groundbreaking breakthroughs. At